<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>11</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>miR-200a Inhibits Tumor Proliferation by Targeting AP-2γ in Neuroblastoma Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>4671</FirstPage>
			<LastPage>4676</LastPage>
			<ELocationID EIdType="pii">29318</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; MicroRNA-200a (miR-200a) has been reported to regulate tumour progression in severaltumours but little is known about its role in neuroblastoma. Our aim was to investigate the potential role andmechanism of miR-200a in neuroblastomas. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Expression levels of miR-200a in tissueswere determined using RT-PCR. The effect of miR-200a and shAP-2γ on cell viability was evaluated using MTSassays, and target protein expression was determined using Western blotting and RT-PCR. Luciferase reporterplasmids were constructed to confirm direct targeting. Results were reported as mean±S.E.M and differenceswere tested for significance using the 2-tailed Students t-test. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: We determined that miR-200a expressionwas significantly lower in neuroblastoma tumors than the adjacent non-cancer tissue. Over-expression of miR-200are reduced cell viability in neuroblastoma cells and inhibited tumor growth in mouse xenografts. We identifiedAP-2γ as a novel target for miR-200a in neuroblastoma cells. Thus miR-200a targets the 3’UTR of AP-2γ andinhibits its mRNA and protein expression. Furthermore, our result showed that shRNA knockdown of AP-2γin neuroblastoma cells results in significant inhibit of cell proliferation and tumor growth in vitro, supportingan oncogenic role of AP-2γ in neuroblastoma. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Our study revealed that miR-200a is a candidatetumor suppressor in neuroblastoma, through direct targeting of AP-2γ. These findings re-enforce the proposalof AP-2γ as a therapeutic target in neuroblastoma.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">miR-200a</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">AP-2γ</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">neuroblastoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cell proliferation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_29318_58a9636938b9cddef4904d3cb3886ca8.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
